跳至主要内容
临床试验/RBR-6yg2z9
RBR-6yg2z9尚未招募未知

Immunochemioprophylaxis in the prevention of Leprosy contacts in children under 15 years of age - WHO - World Health Organization

niversidade Federal de Mato Grosso0 个研究点开始时间: 2019年10月3日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
5Y 至 15Y(—)

入选标准

  • Individuals younger than 15 years (5 years to 14 years, 11 months and 29 days); household contacts of new leprosy cases diagnosed and registered in the National Notification of Injury Information System (SINAN/MT) in 2018 (treatment or treatment virgin) up to 4 weeks of MDT use) of both sexes; who resided or resided within five years before/during the diagnosis of the index case.

排除标准

  • It is those who refuse to undergo the clinical examination; who are diagnosed with leprosy during the examination; those who have a history of hypersensitivity after the previous dose of the vaccine or any component of the vaccine; pregnant women, patients receiving high dose corticosteroids ( 2 mg/kg/day for children up to 10 kg or 20 mg/kg/day for individuals over 10 kg) for a period of more than two weeks; patients taking other immunosuppressive therapies (antineoplastic chemotherapy, radiotherapy, among others).

研究者

发起方
niversidade Federal de Mato Grosso

相似试验